Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 11(1): 1396, 2021 01 14.
Article in English | MEDLINE | ID: mdl-33446751

ABSTRACT

The 7-nitroindolinyl family of caging chromophores has received much attention in the past two decades. However, its uncaging mechanism is still not clearly understood. In this study, we performed state-of-the-art density functional theory calculations to unravel the photo-uncaging mechanism in its entirety, and we compared the probabilities of all plausible pathways. We found competition between a classical cyclization and an acyl migration pathway, and here we explain the electronic and steric reasons behind such competition. The migration mechanism possesses the characteristics of a combined Norrish type I and a 1,6-nitro-acyl variation of a Norrish type II mechanism, which is reported here for the first time. We also found negligible energetic differences in the uncaging mechanisms of the 4-methoxy-5,7-dinitroindolinyl (MDNI) cages and their mononitro analogues (MNI). We traced the experimentally observed improved quantum yields of MDNI to a higher population of the reactants in the triplet surface. This fact is supported by a more favorable intersystem crossing due to the availability of a higher number of triplet excited states with the correct symmetry in MDNI than in MNI. Our findings may pave the way for improved cage designs that possess higher quantum yields and a more efficient agonist release.


Subject(s)
Indoles/chemistry , Models, Chemical , Nitro Compounds/chemistry , Cyclization , Molecular Structure , Photochemistry
2.
ACS Chem Neurosci ; 9(11): 2713-2721, 2018 11 21.
Article in English | MEDLINE | ID: mdl-29750497

ABSTRACT

Glutamate is an excitatory neurotransmitter that controls numerous pathways in the brain. Neuroscientists make use of photoremovable protecting groups, also known as cages, to release glutamate with precise spatial and temporal control. Various cage designs have been developed and among the most effective has been the nitroindolinyl caging of glutamate. We, hereby, report an improved synthesis of one of the current leading molecules of caged glutamate, 4-carboxymethoxy-5,7-dinitroindolinyl glutamate (CDNI-Glu), which possesses efficiencies with the highest reported quantum yield of at least 0.5. We present the shortest route, to date, for the synthesis of CDNI-Glu in 4 steps, with a total reaction time of 40 h and an overall yield of 20%. We also caged glutamate at the other two functional groups, thereby, introducing two new cage designs: α-CDNI-Glu and N-CDNI-Glu. We included a study of their photocleavage properties using UV-vis, NMR, as well as a physiology experiment of a two-photon uncaging of CDNI-Glu in acute hippocampal brain slices. The newly introduced cage designs may have the potential to minimize the interference that CDNI-Glu has with the GABAA receptor. We are broadly disseminating this to enable neuroscientists to use these photoactivatable tools.


Subject(s)
Glutamates/chemical synthesis , Indoles/chemical synthesis , Animals , GABA-A Receptor Antagonists/pharmacology , Glutamates/pharmacology , Glutamic Acid/chemical synthesis , Glutamic Acid/pharmacology , Hippocampus/drug effects , Indoles/pharmacology , Magnetic Resonance Spectroscopy , Mice , Patch-Clamp Techniques , Photolysis , Photons , Receptors, GABA-A
3.
ACS Med Chem Lett ; 5(7): 815-9, 2014 Jul 10.
Article in English | MEDLINE | ID: mdl-25050171

ABSTRACT

5-Oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) is formed by the oxidation of 5-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-HETE), which is a major metabolite of enzymatic oxidation of arachidonic acid (AA). 5-Oxo-ETE is the most potent lipid chemoattractant for human eosinophils. Its actions are mediated by the selective OXE receptor, which is therefore an attractive target in eosinophilic diseases such as allergic rhinitis and asthma. Recently, we have reported two excellent OXE receptor antagonists that have IC50 values at low nanomolar concentrations. Each of these antagonists has a chiral center, and the isolation of the individual enantiomers by chiral high-performance liquid chromatography (HPLC) revealed that in each case one enantiomer is over 300 times more potent than the other. To unambiguously assign the stereochemistry of these enantiomers and to provide access to larger amounts of the active compounds for biological testing, we report here their total synthesis.

4.
Chirality ; 25(9): 575-81, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23801425

ABSTRACT

A two-step stereoselective preparation of a goldfish pheromone, 17α,20ß-dihydroxy-4-pregnen-3-one, is reported from the readily available cortexolone in 64% overall yield. The (20S)-epimer was also synthesized in three steps from cortexolone with an overall yield of 47%. A microscale chiroptical technique based on a host/guest complexation mechanism between the substrate and a dimeric metalloporphyrin host (tweezer) was used to confirm the stereochemical assignment, while Density Functional Theory (DFT) calculations were employed to explain the high stereoselectivity induced by the 17α-hydroxyl and C18-methyl groups.


Subject(s)
Hydroxyprogesterones/chemical synthesis , Metalloporphyrins/chemistry , Optical Tweezers , Pheromones/chemistry , Quantum Theory , Animals , Circular Dichroism , Goldfish , Hydroxyprogesterones/chemistry , Molecular Structure , Optics and Photonics/instrumentation , Optics and Photonics/methods , Pheromones/chemical synthesis , Stereoisomerism
5.
J Med Chem ; 56(9): 3725-32, 2013 May 09.
Article in English | MEDLINE | ID: mdl-23581530

ABSTRACT

5-Oxo-ETE is the most powerful eosinophil chemoattractant among lipid mediators. Eosinophil infiltration into the lungs of asthmatics may be responsible for the late phase of inflammatory asthma. We have designed and synthesized a 5-oxo-ETE receptor antagonist, the purpose of which is to prevent eosinophil migration to the lung during an asthma attack and thereby reduce asthma symptoms.


Subject(s)
Arachidonic Acids/metabolism , Drug Design , Receptors, Eicosanoid/antagonists & inhibitors , Humans , Indoles/chemistry , Indoles/pharmacology , Inhibitory Concentration 50
SELECTION OF CITATIONS
SEARCH DETAIL
...